CHARLES SCHWAB INVESTMENT MANAGEMENT INC - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 76 filers reported holding RECRO PHARMA INC in Q1 2021. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q3 2023$17,375
-57.4%
37,0470.0%0.00%
Q2 2023$40,752
-7.6%
37,0470.0%0.00%
Q1 2023$44,086
-20.1%
37,0470.0%0.00%
Q4 2022$55,200
-9.5%
37,0470.0%0.00%
Q3 2022$61,000
+103.3%
37,0470.0%0.00%
Q2 2022$30,000
-42.3%
37,047
+30.7%
0.00%
Q1 2022$52,000
-62.0%
28,335
-42.2%
0.00%
Q1 2021$137,000
-2.1%
48,9850.0%0.00%
Q4 2020$140,000
+35.9%
48,9850.0%0.00%
Q3 2020$103,000
-53.8%
48,9850.0%0.00%
Q2 2020$223,000
-44.4%
48,9850.0%0.00%
Q1 2020$401,000
-54.4%
48,985
+2.1%
0.00%
Q4 2019$880,000
+72.5%
47,979
+4.4%
0.00%
Q3 2019$510,000
+9.0%
45,9560.0%0.00%
Q2 2019$468,000
+83.5%
45,956
+5.8%
0.00%
Q1 2019$255,000
-49.4%
43,446
-38.7%
0.00%
Q4 2018$504,000
-55.6%
70,927
-55.6%
0.00%
-100.0%
Q3 2018$1,136,000
+28.4%
159,766
-9.3%
0.00%0.0%
Q2 2018$885,000
-57.1%
176,209
-6.0%
0.00%
-50.0%
Q1 2018$2,063,000
+174.3%
187,364
+130.5%
0.00%
+100.0%
Q4 2017$752,000
+174.5%
81,269
+166.5%
0.00%
Q3 2017$274,000
+27.4%
30,5000.0%0.00%
Q2 2017$215,00030,5000.00%
Other shareholders
RECRO PHARMA INC shareholders Q1 2021
NameSharesValueWeighting ↓
Engine Capital Management, LP 872,494$6,195,0003.64%
Newtyn Management, LLC 1,600,000$11,360,0002.22%
Broadfin Capital, LLC 2,048,025$14,541,0001.91%
Balter Liquid Alternatives, LLC 92,167$654,0000.45%
ESSEX INVESTMENT MANAGEMENT CO LLC 515,414$3,660,0000.29%
JT Stratford LLC 45,367$322,0000.21%
Opus Point Partners Management, LLC 11,353$81,0000.18%
Alyeska Investment Group, L.P. 964,000$6,844,0000.10%
KENNEDY CAPITAL MANAGEMENT LLC 500,625$3,554,0000.09%
Monarch Partners Asset Management LLC 55,857$397,0000.06%
View complete list of RECRO PHARMA INC shareholders